Tim A Labeur

besuchte Bildungseinrichtung: Universiteit van Amsterdam

Tätigkeit: Forscher

Reihe

Hier gibt es nichts

Eine neue Serie erstellen

Werke

Hier gibt es nichts

Ein neues Werk erstellen

Artikel 11

Datum

Titel

Autor

2020-01-03

Response to: Prognostication of HCC patients under sorafenib is not always possible

Tim A Labeur, Philip James Johnson
2020-05-05

The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial

Tim A Labeur, Regina Schinner, Peter Malfertheiner, Holger Amthauer, Kerstin Schütte, Bristi Basu, Christiane Kuhl, Julia Mayerle, Jens Ricke, Heinz-Josef Klümpen
2019-11-18

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib

Tim A Labeur, Julien Edeline, Dominik Bettinger, Tim Meyer, David W G Ten Cate, Alessandro Cucchetti, Laura J. Bonnett, Otto M van Delden, Heinz-Josef Klümpen, R Bart Takkenberg, Jeroen L A van Vugt
2019-08-01

Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation

Tim A Labeur
2019-06-08

Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis

Tim A Labeur, Frederike Dijk
2018-06-26

Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma

Tim A Labeur, David W G Ten Cate, R Bart Takkenberg, Hicham Azahaf, Martijn G H van Oijen, Otto M van Delden, Jeroen L A van Vugt, Jan N M IJzermans, Heinz-Josef Klümpen
2018-11-02

Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib

Tim A Labeur, Jeroen L A van Vugt, Bas Groot Koerkamp
2018-11-28

Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma

Tim A Labeur
2017-09-25

The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma

Robert J S Coelen, Tim A Labeur, Jeroen L A van Vugt, Bas Groot Koerkamp
2017-05-19

Validation of the Mayo Clinic Staging System in Determining Prognoses of Patients With Perihilar Cholangiocarcinoma.

Robert J S Coelen, Tim A Labeur, Jan N M IJzermans, Jeroen L A van Vugt, Bas Groot Koerkamp
2017-05-23

Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases

Stefan Buettner, Robert J S Coelen, Tim A Labeur, Harveshp Mogal, Timothy Pawlik, Eliza W Beal, Shishir K Maithel, Jeroen L A van Vugt, Charles R. Scoggins, Robert C G Martin, Cecilia G Ethun, Sharon M. Weber, Bas Groot Koerkamp

Mensch - wd:Q88165393

Willkomen bei Inventaire

die Bibliothek deiner Freunde und Communitys

entdecke mehr